×

The Bile Acids Expert

ICE Pharma offers an extensive portfolio of products and services for the pharmaceutical and healthcare markets. We have a unique range of bile acid products and are a leading global integrated producer of Ursodeoxycholic acid (UDCA).

View our Product range View our services

Continue scrolling

Our company

An unmatched experience and expertise

With over 70 years of experience and 1500 world-wide employees, ICE Pharma provides both products and services to the pharmaceutical industry.

ICE Pharma is an expert in the development and manufacture of bile acid derivatives. We are a leading producer of Ursodeoxycholic Acid (UDCA) with an integrated global manufacturing network in Europe, Latin America, Asia and Oceania that serves customers in over 50 countries.

Our five R&D centres have enabled us to develop a unique and comprehensive range products including Generic APIs, Excipients, Finished Dosage Forms and New Chemical Entities.

Find out more

Our Products & Services

We offer a comprehensive & unique range of products & services

Learn more

Pharmaceutical

We offer an extensive range of products for the pharmaceutical market including APIs, Finished Dosage Forms and Excipients.

Find out more

CDMO Services

We provide pharmaceutical contract development and manufacturing services for solid and liquid finished dosage forms and complex carbohydrates

Find out more

Nutraceutical

Our range of branded nutraceutical supplements is focused on strengthening the immune system and gut health. We are also a provider of natural taurine.

Find out more

Research Chemicals

We supply the academic and research communities with complex carbohydrates and novel bile acid derivatives.

Find out more

Cosmetics

Our branded natural cosmetics range is focused on skin care.

Find out more

Our global footprint

Facilities & companies across the globe

ICE Pharma has an interconnected network of 7 manufacturing facilities in North and South America, Europe, Asia and Oceania through which we provide our customers with an unparalleled security of supply and a local service.

Find out more

News & Articles

Stay up to date with ICE Pharma’s latest news, events & publications

Company HighlightsInsights
December 2, 2022

ICE Pharma published the Sustainability Report 2021/2022

During 2022, ICE Pharma developed a long-term sustainability strategy and a short-term roadmap that will guide our actions for the next three years. We describe the strategic choices that...

Company HighlightsICEJapan
May 3, 2022

ICE Pharma acquires Iwaki manufacturing site from Mitbubishi API corporation

We are pleased to announce that on May 2nd ICE Pharma completed the purchase of the Iwaki Ursodeoxycholic Acid (“UDCA”) manufacturing site from Mitsubishi API Corporation. This transaction represents...

ArticlesCompany Highlights
April 6, 2022

Third research publication in collaboration with ICE Pharma and Ferrier Research Institute

Synthesis of Novel C/D Ring Modified Bile Acids Bile acid receptors have been identified as important targets for the development of new therapeutics to treat various metabolic and inflammatory...

Contact us

Your pharmaceutical product or service is just a click away

Contact us today and an one of our experts will reply immediately to discuss your requirements.

Find out more